← Leaderboards
Harvey Ira Pass
New York University School Of Medicine
$7,723,189
Attributed
$13,395,284
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,087,299 · 5
By mechanism
U01$12,823,999 · 3
U2C$2,692,015 · 1
P01$571,285 · 1
Top collaborators
- Margaret Elisabeth Huflejt7 shared
- Haining Yang6 shared
- Carlo M Croce5 shared
- Leopoldo Nicolas Segal3 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Steven J Burden$20,147,110
- James L Salzer$22,072,768
- Dayu Lin$20,017,243
- Ravinder R Regatte$21,435,259
- Vivek Jay Srinivasan$12,444,709
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCohortInvestigationPlasmaCessation Of LifeEarly DiagnosisHigh RiskMesotheliomaAsbestosValidationSamplingBiological MarkersPrognosticTumorBaseSpecimenGenesMalignant Pleural MesotheliomaTissuesArchivesMalignant - DescriptorLaboratoriesDiagnosisBlood
Grant awards (30)
Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer$1,019,623
U2C · FY2025 · CA
Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer$968,968
U2C · FY2024 · CA
Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer$703,424
U2C · FY2023 · CA
The EDRN Mesothelioma Biomarker Discovery Laboratory$221,028
U01 · FY2021 · CA · contact PI
The EDRN Mesothelioma Biomarker Discovery Laboratory$547,589
U01 · FY2020 · CA · contact PI
The EDRN Mesothelioma Biomarker Discovery Laboratory$479,690
U01 · FY2019 · CA · contact PI
The EDRN Mesothelioma Biomarker Discovery Laboratory$812,360
U01 · FY2018 · CA · contact PI
Identifying non-coding RNAs for early detection and prevention of lung cancer$915,659
U01 · FY2017 · CA
The EDRN Mesothelioma Biomarker Discovery Laboratory$812,360
U01 · FY2017 · CA · contact PI
Identifying non-coding RNAs for early detection and prevention of lung cancer$897,104
U01 · FY2016 · CA
The EDRN Mesothelioma Biomarker Discovery Laboratory$580,136
U01 · FY2016 · CA · contact PI
The North American Mesothelioma Consortium$324,128
U01 · FY2016 · CA · contact PI
Identifying non-coding RNAs for early detection and prevention of lung cancer$905,221
U01 · FY2015 · CA
The North American Mesothelioma Consortium$178,092
U01 · FY2015 · CA · contact PI
Identifying non-coding RNAs for early detection and prevention of lung cancer$851,643
U01 · FY2014 · CA
The North American Mesothelioma Consortium$541,687
U01 · FY2014 · CA · contact PI
Identifying non-coding RNAs for early detection and prevention of lung cancer$967,089
U01 · FY2013 · CA
The North American Mesothelioma Consortium$544,278
U01 · FY2013 · CA · contact PI
The North American Mesothelioma Consortium$579,019
U01 · FY2012 · CA · contact PI
The North American Mesothelioma Consortium$579,020
U01 · FY2011 · CA · contact PI
The North American Mesothelioma Consortium$608,087
U01 · FY2010 · CA · contact PI
CLINICAL CORE$115,716
P01 · FY2010 · CA · contact PI
CLINICAL CORE$114,283
P01 · FY2009 · CA · contact PI
American/Australian Mesothelioma Consortium$169,500
U01 · FY2008 · CA · contact PI
CLINICAL CORE$109,512
P01 · FY2008 · CA · contact PI
American/Australian Mesothelioma Consortium$433,230
U01 · FY2007 · CA · contact PI
CLINICAL CORE$107,113
P01 · FY2007 · CA · contact PI
American/Australian Mesothelioma Consortium$440,345
U01 · FY2006 · CA · contact PI
CLINICAL CORE$124,661
P01 · FY2006 · CA · contact PI
American/Australian Mesothelioma Consortium$436,734
U01 · FY2005 · CA